V009-1552 Screening compound: 4-[3-(benzylamino)-7-methylimidazo[1,2-a]pyridin-2-yl]-2-methoxyphenyl cyclohexanecarboxylate

V009-1552 Screening compound: 4-[3-(benzylamino)-7-methylimidazo[1,2-a]pyridin-2-yl]-2-methoxyphenyl cyclohexanecarboxylate
V009-1552 Screening compound: 4-[3-(benzylamino)-7-methylimidazo[1,2-a]pyridin-2-yl]-2-methoxyphenyl cyclohexanecarboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-1552
4-[3-(benzylamino)-7-methylimidazo[1,2-a]pyridin-2-yl]-2-methoxyphenyl cyclohexanecarboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-1552

Molecular Formula

C29H31N3O3 (C29 H31 N3 O3)

Compound Name

4-[3-(benzylamino)-7-methylimidazo[1,2-a]pyridin-2-yl]-2-methoxyphenyl cyclohexanecarboxylate

IUPAC name

4-[3-(benzylamino)-7-methylimidazo[12-a]pyridin-2-yl]-2-methoxyphenyl cyclohexanecarboxylate

SMILES

Cc1cc2nc(-c(cc3)cc(OC)c3OC(C3CCCCC3)=O)c(NCc3ccccc3)n2cc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

469.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.950

Distribution Coefficient, logD

5.947

Water Solubility, LogSw

-5.38

Polar Surface Area

47.288

Acid Dissociation Constant (pKa)

20.53

Base Dissociation Constant (pKb)

5.21

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.00

V009-1552 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V009-1552 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-1552?
Check Price and Availability of V009-1552, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-1552 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-1552
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-1552
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-1552 available by request